Clevidipine
- Generic Name
- Clevidipine
- Brand Names
- Cleviprex
- Drug Type
- Small Molecule
- Chemical Formula
- C21H23Cl2NO6
- CAS Number
- 167221-71-8
- Unique Ingredient Identifier
- 19O2GP3B7Q
Overview
Clevidipine is a dihydropyridine L-type calcium channel blocker that is selective for vascular smooth muscle and is indicated for blood pressure reduction when oral therapy is not an option.
Background
Clevidipine is a dihydropyridine L-type calcium channel blocker that is selective for vascular smooth muscle and is indicated for blood pressure reduction when oral therapy is not an option.
Indication
For the reduction of blood pressure when when oral antihypertensive therapy is not feasible or not desirable.
Associated Conditions
- Hypertension
Clinical Trials
FDA Approved Products
Cleviprex
Manufacturer:Chiesi USA, Inc.
Route:INTRAVENOUS
Strength:0.5 mg in 1 mL
Approved: 2022/09/06
NDC:10122-611
Cleviprex
Manufacturer:Chiesi USA, Inc.
Route:INTRAVENOUS
Strength:0.5 mg in 1 mL
Approved: 2022/09/06
NDC:10122-610
Cleviprex
Manufacturer:Fresenius Kabi Austria GmbH
Route:INTRAVENOUS
Strength:0.5 mg in 1 mL
Approved: 2018/12/28
NDC:18124-011
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath